What You Should Know:
- Omniscient (o8t®), a Sydney, Australia-based global leader in applying AI to unlock the secrets of the human brain, announced today the successful conclusion of its Series C funding round. This round brings the company's total capital raised to US$60M , marking a significant milestone in its growth trajectory.
- The funding round highlights the confidence of prominent Australian investors, including Will Vicars and Gina Rinehart, in Omniscient's vision and
Read More
neurological conditions
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months.
Parkinson’s Disease Premium Dataset
Nearly
Read More
Behavidence Raises $4.3M to Expand AI-Driven Psychiatric & Neurological Disorders Monitoring
What You Should Know:
- Behavidence, a behavioral health company that monitors psychiatric and neurological disorders using artificial intelligence, announced a $4.3M seed round led by Welltech Ventures, featuring Arc Impact and Longevity Ventures.
- Founded in 2020, Behavidence offers multiple digital phenotyping models that can predict disorders such as depression, anxiety, ADHD and more. These digital phenotyping solutions have been adopted by health organizations, tech, commercial and
Read More
From Analog to Digital Neurology: 3 Steps to Better Inform Patient Care
The field of neurology is at an inflection point. With a growing aging population, neurologists are facing an increasing number of patients needing care, and the pent-up demand for services due to COVID-19 only exacerbates this issue. The pressure on neurologists is enormous, with surveys indicating excessive stress caused by inefficient workflow and mounting paperwork 1,2. It is becoming increasingly clear that the traditional analog neurological exam and referral system is overwhelmed, and
Read More
NeuroFlow Partners with Wounded Warrior Project for Remote Behavioral Health Support
What You Should Know:
- During National Caregivers Month, Wounded Warrior
Project and NeuroFlow are joining forces to raise awareness and access for
mental health by providing access to new technology tools and care options
- There are 53 million Americans who are unpaid
caregivers to family, friends, neighbors and spouses. This shared burden is
also widespread in the military community as many veterans and their caregivers
battle silent burdens.
NeuroFlow, the leader in
Read More
AiCure Launches Platform to Remotely Capture Digital Biomarkers in Clinical Trials
What You Should Know:
- AiCure launches digital biomarker platform to remotely detect subtle changes in a patient's condition, leverages computer vision and AI to gather and analyze visual and auditory cues directly through the patient's smartphone camera.
- AiCure appoints Ed Ikeguchi, M.D. as its Chief Executive Officer (CEO) to advance AiCure's commitment to improving holistic health through an understanding of the science behind human responses to illness and treatment.
AiCure,
Read More
VA St. Louis to Provide Veterans with VR Therapy for Medical Conditions
- VA St. Louis Healthcare System announces a partnership with XRHealth to provide virtual reality (VR) therapy for veterans. XRHealth’s VR therapy platform will assist veterans in gaining relief from spinal cord injuries, amputations, poly-trauma, multiple sclerosis, or other neurological conditions.XRHealth, formerly known as VRHealth, a Boston, MA-based provider of extended reality and therapeutic applications, today announced that they partnered with the VA St. Louis Healthcare System to
Read More
Philips Debuts AI-Driven Clinical Solution for Aiding Cognitive Assessment in the U.S.
- Philips IntelliSpace Cognition provides U.S. healthcare professionals with a powerful aid for assessing cognitive impairments due to neurological conditions.
- Philips has invested in collecting insights from both neurologists and neuropsychologists in order to design IntelliSpace Cognition in an iterative manner and ensure it fits into the majority of existing workflows.
- IntelliSpace Cognition will initially be commercially available only in the U.S.
Philips, a global leader in
Read More
Accenture, Biogen, 1QBit Launch Quantum Computing App to Accelerate Drug Discovery
Accenture and Biogen have developed a first-of-a-kind quantum-enabled molecular comparison app designed to speed up drug discovery for complex neurological conditions such as MS, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease. Researchers at Accenture Labs collaborated with 1QBit to create the new application which enhances Biogen’s existing molecule comparison method with quantum capabilities.Molecular comparison is a crucial part of early-phase drug design and discovery, and involves
Read More